Thomas J. Westrick - 01 Mar 2023 Form 4 Insider Report for GE HealthCare Technologies Inc. (GEHC)

Role
CEO, Patient Care Solutions
Signature
/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact
Issuer symbol
GEHC
Transactions as of
01 Mar 2023
Net transactions value
-$120,634
Form type
4
Filing time
03 Mar 2023, 18:55:49 UTC
Previous filing
29 Dec 2023
Next filing
05 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GEHC Common Stock, par value $0.01 per share Award $0 +3,652 +25% $0.000000 18,161 01 Mar 2023 Direct F1, F2
transaction GEHC Common Stock, par value $0.01 per share Tax liability $78,237 -1,039 -5.7% $75.30 17,122 01 Mar 2023 Direct F3
transaction GEHC Common Stock, par value $0.01 per share Tax liability $42,398 -565 -3.3% $75.04 16,557 02 Mar 2023 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GEHC Employee Stock Option (right to buy) Award +10,188 10,188 01 Mar 2023 Common Stock, par value $0.01 per share 10,188 $75.30 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 33% will vest on September 1, 2024, 33% will vest on September 1, 2025, and 34% will vest on September 1, 2026.
F2 Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.
F3 Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
F4 Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2024, 33% will become exercisable on September 1, 2025, and 34% will become exercisable on September 1, 2026.